Home
Home

Relistor

Strong Relistor Sales Drive New Rally In Progenics

Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha

Progenics Plummets On Rejection Of New Use Of Relistor Drug

Progenics Plummets On Rejection Of New Use Of Relistor Drug
Bloomberg

Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA

Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA
Yahoo/BusinessWire

Vivus, Onyx, Amarin Await Key Dates in July

Vivus, Onyx, Amarin Await Key Dates in July
Minyanville

FDA Action Date for Salix's Relistor

FDA Action Date for Salix's Relistor
Yahoo/Zacks.com

Salix Pharma Says FDA Accepts SNDA Filing For RELISTOR For Non-Cancer Pain

Salix Pharma Says FDA Accepts SNDA Filing For RELISTOR For Non-Cancer Pain
RTT News

News

Possible New Indication for Progenics' Relistor Could Revive Its Fortunes
Seeking Alpha
»

News

Wyeth Quits On Relistor; Surprise Victory in First REMS Test Market
InVivo
»

News

Progenics Regains Relistor Rights
TheStreet.com
»